State Street Corp Has $3.20 Billion Stock Position in Becton, Dickinson and Company (NYSE:BDX)

State Street Corp grew its position in Becton, Dickinson and Company (NYSE:BDXGet Rating) by 3.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,705,205 shares of the medical instruments supplier’s stock after buying an additional 480,684 shares during the quarter. State Street Corp’s holdings in Becton, Dickinson and were worth $3,195,105,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Accel Wealth Management lifted its position in shares of Becton, Dickinson and by 100.0% in the fourth quarter. Accel Wealth Management now owns 100 shares of the medical instruments supplier’s stock worth $25,000 after purchasing an additional 50 shares in the last quarter. Sierra Capital LLC lifted its position in shares of Becton, Dickinson and by 88.7% in the fourth quarter. Sierra Capital LLC now owns 100 shares of the medical instruments supplier’s stock worth $25,000 after purchasing an additional 47 shares in the last quarter. Level Financial Advisors Inc. purchased a new stake in shares of Becton, Dickinson and in the fourth quarter worth approximately $26,000. Fortis Advisors LLC purchased a new stake in shares of Becton, Dickinson and in the third quarter worth approximately $27,000. Finally, Eagle Bay Advisors LLC lifted its position in shares of Becton, Dickinson and by 64.9% in the third quarter. Eagle Bay Advisors LLC now owns 155 shares of the medical instruments supplier’s stock worth $37,000 after purchasing an additional 61 shares in the last quarter. Institutional investors own 86.58% of the company’s stock.

BDX has been the topic of several recent research reports. Piper Sandler cut their price objective on shares of Becton, Dickinson and from $265.00 to $255.00 in a research report on Thursday, May 5th. Wells Fargo & Company raised their price objective on shares of Becton, Dickinson and from $275.00 to $285.00 and gave the company an “equal weight” rating in a research report on Friday, April 1st. Bank of America initiated coverage on shares of Becton, Dickinson and in a research report on Tuesday, March 1st. They set a “neutral” rating on the stock. StockNews.com lowered shares of Becton, Dickinson and from a “buy” rating to a “hold” rating in a research report on Wednesday. Finally, Argus raised their price objective on shares of Becton, Dickinson and from $275.00 to $310.00 in a research report on Monday, February 28th. Six analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $276.43.

Becton, Dickinson and stock opened at $256.46 on Friday. The firm has a market cap of $73.11 billion, a price-to-earnings ratio of 40.45, a P/E/G ratio of 4.15 and a beta of 0.64. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.52 and a quick ratio of 1.04. Becton, Dickinson and Company has a fifty-two week low of $235.13 and a fifty-two week high of $280.62. The firm has a fifty day moving average price of $259.71 and a two-hundred day moving average price of $258.00.

Becton, Dickinson and (NYSE:BDXGet Rating) last released its earnings results on Thursday, May 5th. The medical instruments supplier reported $3.18 earnings per share for the quarter, topping analysts’ consensus estimates of $2.98 by $0.20. The firm had revenue of $5.01 billion during the quarter, compared to analyst estimates of $4.78 billion. Becton, Dickinson and had a net margin of 9.59% and a return on equity of 14.91%. The business’s revenue was up 2.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.19 EPS. As a group, sell-side analysts expect that Becton, Dickinson and Company will post 11.19 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 30th. Stockholders of record on Thursday, June 9th will be given a dividend of $0.87 per share. This represents a $3.48 dividend on an annualized basis and a dividend yield of 1.36%. Becton, Dickinson and’s dividend payout ratio is currently 54.89%.

In other news, EVP David Hickey sold 475 shares of the company’s stock in a transaction dated Friday, May 6th. The shares were sold at an average price of $256.00, for a total transaction of $121,600.00. Following the completion of the transaction, the executive vice president now owns 3,806 shares of the company’s stock, valued at $974,336. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.50% of the stock is currently owned by corporate insiders.

Becton, Dickinson and Profile (Get Rating)

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems.

See Also

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDXGet Rating).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.